Answers are grounded in this paper and cite their sources.
haploinsufficient mice. In nonhuman primates, widespread vector biodistribution and transgene expression were observed in the central nervous system after unilateral ICV administration of AAV9-STXBP1 vectors. The vectors were well tolerated, and addition of the detargeting regulatory element significantly reduced expression in DRG, while ameliorating histopathologic effects and functional nerve conduction alterations. Taken together, these data support the feasibility of a one-time AAV-based therapeutic approach for STXBP1-related disorders.
No takes yet. Share an insight, caveat, or question.
Aeran et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: